Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to $72000.0.

  • Lisata Therapeutics' Other Non-Current Liabilities changed 0.0% to $72000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $72000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $72000.0 for FY2024, which is 6571.43% down from last year.
  • According to the latest figures from Q3 2025, Lisata Therapeutics' Other Non-Current Liabilities is $72000.0, which was down 0.0% from $72000.0 recorded in Q2 2025.
  • Lisata Therapeutics' Other Non-Current Liabilities' 5-year high stood at $337000.0 during Q1 2023, with a 5-year trough of $72000.0 in Q3 2024.
  • For the 3-year period, Lisata Therapeutics' Other Non-Current Liabilities averaged around $158000.0, with its median value being $119000.0 (2024).
  • In the last 5 years, Lisata Therapeutics' Other Non-Current Liabilities tumbled by 7154.15% in 2024 and then changed by 0.0% in 2025.
  • Lisata Therapeutics' Other Non-Current Liabilities (Quarter) stood at $210000.0 in 2023, then tumbled by 65.71% to $72000.0 in 2024, then changed by 0.0% to $72000.0 in 2025.
  • Its Other Non-Current Liabilities stands at $72000.0 for Q3 2025, versus $72000.0 for Q2 2025 and $72000.0 for Q1 2025.